Astellas Submits New Drug Application for Conditional Approval of Avacincaptad Pegol for Geographic Atrophy in Japan

- Ministry of Health, Labour and Welfare to evaluate ACP as potential first and only treatment for patients with geographic atrophy (GA) secondary to age-related macular degeneration (AMD) in Japan - TOKYO, Feb. 5, 2025 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503) (President and CEO:...